Recombinant Rat Interferon-induced transmembrane protein 3 (ifitm3)

What is rat IFITM3 and what are its primary biological functions?

Rat IFITM3 (Interferon-induced transmembrane protein 3) is a small transmembrane protein that plays critical roles in innate immunity and viral restriction. It belongs to the IFITM family of proteins that are highly conserved across vertebrates. The primary functions of rat IFITM3 include:

• Restriction of viral entry and replication for multiple pathogens

• Modulation of inflammatory responses in various tissues

• Participation in cellular membrane organization and dynamics

• Regulation of primordial germ cell clustering and regionalization

The rat IFITM3 protein (UniProt ID: P26376, Gene ID: 361673) functions similarly to its human ortholog but with species-specific differences in regulation and activity against certain viruses .

How can I accurately measure rat IFITM3 expression in experimental samples?

Several validated methods are available for measuring rat IFITM3 expression:

Protein level detection:

• ELISA: Sandwich ELISA kits are available with detection sensitivity <14 pg/ml and test range of 31.2-2000 pg/ml, suitable for tissue homogenates, cell lysates, and biological fluids

• Western blotting: Using validated anti-rat IFITM3 antibodies

• Immunohistochemistry/Immunofluorescence: For tissue localization studies

Transcript level detection:

• Quantitative RT-PCR: Particularly useful for measuring transcriptional responses to stimuli

• RNA-Seq: For comprehensive transcriptomic profiling

For qRT-PCR analysis, researchers should note that interferon stimulation significantly upregulates Ifitm3 transcript levels. Studies have demonstrated that IFN-alpha2 (500 ng/ml) and IFN-gamma (100 ng/ml) significantly increase Ifitm3 mRNA expression, while OSM (250 ng/ml) and IL-6 (250 ng/ml) may also upregulate Ifitm3 in specific cell types .

What experimental models are most suitable for studying rat IFITM3 function?

Several experimental models have proven effective for studying rat IFITM3:

In vitro models:

• Primary rat cell cultures (particularly immune cells like macrophages and dendritic cells)

• Rat cell lines (specific for studying tissue-relevant functions)

• Bone marrow-derived dendritic cells (BM-DCs) for studying IFITM3's role in restricting virus-induced inflammatory cytokine production

In vivo models:

• Wildtype rats for normal expression patterns

• IFITM3 knockout or knockdown models (using CRISPR/Cas9 or siRNA technologies)

• Inducible expression systems for temporal control

When selecting an experimental model, consider that IFITM3 expression is differentially regulated across tissues and can be significantly induced by interferons and other cytokines. For comparative studies, mouse IFITM3 knockout models have demonstrated the protein's importance in protecting against viral infections, particularly in cardiac tissue .

How does rat IFITM3 expression respond to different cytokines and inflammatory stimuli?

Rat IFITM3 shows distinct expression patterns in response to various cytokines and inflammatory signals:

For experimental design, it's important to note that cytokine induction of IFITM3 is time-dependent, with peak expression typically observed after 24 hours of stimulation.

What roles does rat IFITM3 play in viral infections, and which viruses are affected?

Rat IFITM3, like its human and mouse orthologs, plays crucial roles in restricting multiple viral infections through several mechanisms:

Antiviral mechanisms:

• Inhibition of virus-cell fusion

• Restriction of viral entry at the plasma membrane

• Interference with virus trafficking in endosomal compartments

• Modulation of membrane fluidity

Affected viruses:

• Influenza A virus (IAV)

• HIV-1

• SARS-CoV and SARS-CoV-2

• Flaviviruses (including Dengue virus)

• Filoviruses (including Ebola virus)

Studies on mouse IFITM3 have demonstrated its critical role in preventing efficient dissemination and replication of influenza virus in heart tissue, limiting cardiac pathology during infection. IFITM3 knockout mice exhibit increased virus loads in multiple tissues, including the heart, lungs, and spleen, demonstrating the protein's importance in systemic viral restriction .

What techniques are optimal for studying rat IFITM3 protein-protein interactions?

Several techniques have proven effective for investigating IFITM3 protein-protein interactions:

In vitro techniques:

• Co-immunoprecipitation: Using tagged versions of rat IFITM3

• Proximity ligation assay: For detecting interactions in fixed cells

• FRET/BRET: For analyzing interactions in living cells

• Cross-linking studies: Particularly useful for IFITM3's interaction with the γ-secretase complex

Advanced approaches:

• Photo-affinity probes coupled with mass spectrometry: Used successfully to identify IFITM3's interaction with γ-secretase

• Bimolecular fluorescence complementation: For visualizing interaction sites within cells

• Pull-down assays with recombinant proteins: For direct interaction studies

When studying IFITM3's interaction with γ-secretase, researchers have effectively used small molecule γ-secretase modulators (GSMs) with photo-affinity probes and UV cross-linking to identify proteins that associate with active γ-secretase complexes .

How does the membrane topology of rat IFITM3 influence its antiviral activity?

The membrane topology of IFITM3 is critical for its antiviral function and has been the subject of intensive research:

Current structural understanding:

• IFITM3 adopts a specific membrane topology that is essential for its restriction of viral fusion

• Researchers have developed structural models of IFITM3 consistent with experimental predictions on its membrane topology

• The AlphaFold model (AF-Q01628-F1) differs from experimentally validated models (RMSD of 3.5 Å), predicting IFITM3 as a type II transmembrane protein

Methodological approaches for studying topology:

• Molecular dynamics simulations in membrane-aqueous environments

• Structural modeling validated by Ramachandran plots and ProSA-web assessment

• Protein preparation with H-bond optimization and constrained minimization

• RMSD stabilization analysis during simulation (typically stabilizing after 20 ns)

The membrane topology directly affects IFITM3's ability to modulate membrane properties and interact with viral fusion machinery. Understanding this topology is essential for developing strategies to enhance or mimic IFITM3's antiviral activity.

What is the role of the GxxxG motif in rat IFITM3 oligomerization and function?

The GxxxG motif represents a critical structural element in IFITM3 that mediates protein-protein interactions:

Key findings regarding the GxxxG motif:

• Glycine-95 of human IFITM3 (with corresponding positions in rat IFITM3) resides within a GxxxG motif that is highly conserved among vertebrate IFITM3 orthologs

• This motif mediates IFITM3 oligomerization in living cells, with glycine-95 playing a dominant role

• Mutation of glycine-91 or glycine-95 significantly reduces IFITM3's activity against influenza A virus (in target cells) and HIV-1 (in virus-producing cells)

• An IFITM3 G95L mutant exhibits loss of antiviral function and is deficient for oligomerization, indicating that the GxxxG motif is essential for forming functional IFITM3 oligomers

Experimental approaches to study the GxxxG motif:

• Site-directed mutagenesis of conserved glycine residues

• Oligomerization assays in living cells

• Functional antiviral assays with GxxxG mutants

• Biophysical characterization of wild-type and mutant proteins

This research highlights the importance of IFITM3 oligomerization for its antiviral activity and identifies the GxxxG motif as a critical determinant of this function.

How does IFITM3 connect neuroinflammation to amyloid-beta production in neurodegenerative disease models?

Recent research has uncovered a fascinating link between IFITM3, neuroinflammation, and amyloid-beta (Aβ) production relevant to neurodegenerative diseases:

Mechanistic findings:

• IFITM3 binds to γ-secretase and increases the enzyme's production of Aβ peptides

• Knocking down IFITM3 reduces Aβ production in human cells and in a mouse model of amyloidosis (5xFAD mice)

• In the human brain, IFITM3 levels increase with age and in Alzheimer's disease (AD)

• IFITM3 levels correlate with the amount of inflammatory cytokines and viral proteins present in the brain

Experimental approaches to study this connection:

• Molecular interaction studies between IFITM3 and γ-secretase components

• Quantification of Aβ production in the presence/absence of IFITM3

• Correlation analyses of IFITM3, inflammatory markers, and Aβ levels in brain tissue

• Animal models with IFITM3 manipulation in the context of neurodegeneration

This research "turns the classical view that inflammation is a consequence of amyloid plaque accumulation upside-down, providing mechanistic support for the hypothesis that inflammation causes increased Aβ generation" . It suggests IFITM3 as a potential therapeutic target linking age-related neuroinflammation with increased Aβ production.

What methodological approaches can address contradictory data about IFITM3's role in specific disease contexts?

Researchers investigating IFITM3 in different disease contexts may encounter contradictory data. Several methodological approaches can help address these contradictions:

Systematic approaches:

• Comprehensive knockout models: Generate complete IFITM3 knockout models on pure genetic backgrounds (e.g., C57BL/6) using CRISPR/Cas9-based deletion strategies targeting specific exons

• Validation of model specificity: Confirm specificity by RT-PCR for related family members (IFITM1, IFITM2) and sequencing of potential off-target sites

• Multi-tissue analysis: Examine virus replication and protein levels across multiple tissues (lungs, heart, spleen) to identify tissue-specific effects

• Temporal dynamics: Study disease progression over time, particularly in infection models with varying pathogenicity

• Comparative virus strains: Use different virus strains with varying virulence to distinguish between strain-specific and general effects of IFITM3

Advanced analytical techniques:

• Transcriptomic profiling to identify compensatory mechanisms

• Systems biology approaches to model complex interactions

• Single-cell analysis to identify cell-specific responses

• Tissue-specific conditional knockouts to separate systemic from local effects

These approaches have successfully resolved apparent contradictions in IFITM3 research, such as demonstrating that IFITM3 knockout mice can recover from sublethal infections despite impaired control of virus levels in specific tissues, suggesting functional adaptive immune responses despite IFITM3 deficiency .

What are the optimal conditions for producing and purifying recombinant rat IFITM3?

Production of functional recombinant rat IFITM3 requires careful consideration of expression systems and purification strategies:

Expression systems:

• Bacterial systems: Challenging due to IFITM3's membrane protein nature, but possible with fusion tags or inclusion body refolding

• Mammalian expression: Preferred for proper post-translational modifications

• Insect cell systems: Good compromise between yield and proper folding

Purification strategies:

• Affinity chromatography using His, GST, or specialized tags

• Size exclusion chromatography for oligomeric state separation

• Detergent selection critical for maintaining native conformation

Critical considerations:

• Membrane protein solubilization requires careful detergent selection

• The GxxxG motif influences oligomerization state

• Post-translational modifications may be important for function

• Maintain proper membrane topology during purification

For functional assays, it's essential to verify that the recombinant protein maintains its native membrane topology and oligomerization potential, which are critical for its antiviral activity.

How can researchers effectively design IFITM3 knockout or knockdown models in rats?

Design of effective IFITM3 knockout or knockdown models requires strategic approaches:

CRISPR/Cas9 knockout strategies:

• Target early exons (e.g., exon 1) to ensure complete protein disruption

• Design guide RNAs with unique sequence identity for specific regions of exon 1

• Validate knockouts by PCR, sequencing, and protein expression analysis

• Confirm specificity by checking expression of related family members (IFITM1, IFITM2)

RNAi knockdown approaches:

• Design siRNAs targeting conserved regions of the IFITM3 transcript

• Use multiple siRNAs to confirm phenotype specificity

• Include appropriate controls (scrambled sequences, unrelated targets)

• Validate knockdown efficiency at both mRNA and protein levels

Validation requirements:

• Confirm the absence of IFITM3 protein by immunoblotting, even after interferon treatment

• Screen for off-target effects by sequencing predicted sites

• Assess the expression of other IFITM family members to ensure specificity

• Test functional phenotypes relevant to IFITM3's known roles

These approaches have been successfully implemented in mouse models, creating clean genetic deficiencies on pure genetic backgrounds that have revealed critical roles for IFITM3 in protecting against viral infections, particularly in cardiac tissue .

What are emerging research areas for rat IFITM3 beyond viral restriction?

While IFITM3's role in viral restriction is well-established, several emerging research areas warrant further investigation:

Neuroinflammation and neurodegeneration:

• IFITM3's interaction with γ-secretase and enhancement of Aβ production suggests important roles in Alzheimer's disease pathogenesis

• The correlation between IFITM3 levels, inflammatory cytokines, and viral proteins in the brain opens new avenues for understanding neurodegeneration mechanisms

Cardiac pathophysiology:

• IFITM3's protection against cardiac pathology during viral infections suggests potential roles in other cardiac conditions

• The activation of fibrotic pathways and cardiac electrical dysfunction in IFITM3-deficient models warrants investigation in non-infectious cardiac disorders

Immune regulation beyond viral responses:

• IFITM3's restriction of virus-induced inflammatory cytokine production by dendritic cells suggests broader immunomodulatory functions

• Potential roles in regulating inflammation in autoimmune and inflammatory conditions

Developmental biology:

• IFITM3's involvement in primordial germ cell clustering and regionalization suggests important developmental functions

• Potential roles in tissue patterning and cellular differentiation

These emerging areas represent promising directions for researchers to expand our understanding of IFITM3 beyond its established antiviral functions.

What technological advances will enhance future rat IFITM3 research?

Several technological advances are poised to transform IFITM3 research:

Structural biology innovations:

• Cryo-EM for membrane protein complexes containing IFITM3

• Advanced computational modeling approaches beyond AlphaFold

• Hydrogen-deuterium exchange mass spectrometry for dynamic structural analysis

• Improved molecular dynamics simulations in membrane environments

Gene editing and expression technologies:

• CRISPR-based approaches for precise genomic modifications

• Inducible and tissue-specific knockout systems

• Single-cell transcriptomics and proteomics

• In vivo imaging of IFITM3 localization and dynamics

Functional screening platforms:

• High-throughput screening for IFITM3 modulators

• PROTAC and molecular glue approaches for targeted IFITM3 degradation

• Humanized rat models for translational research

• Organ-on-chip technologies for tissue-specific IFITM3 function studies